240 related articles for article (PubMed ID: 29705708)
1. Design, synthesis, structure-activity relationships and X-ray structural studies of novel 1-oxopyrimido[4,5-c]quinoline-2-acetic acid derivatives as selective and potent inhibitors of human aldose reductase.
Crespo I; Giménez-Dejoz J; Porté S; Cousido-Siah A; Mitschler A; Podjarny A; Pratsinis H; Kletsas D; Parés X; Ruiz FX; Metwally K; Farrés J
Eur J Med Chem; 2018 May; 152():160-174. PubMed ID: 29705708
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and structure-activity relationship studies of quinoxaline derivatives as aldose reductase inhibitors.
Wu B; Yang Y; Qin X; Zhang S; Jing C; Zhu C; Ma B
ChemMedChem; 2013 Dec; 8(12):1913-7. PubMed ID: 24115741
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis, and biological evaluation of novel (1-thioxo-1,2,3,4-tetrahydro-β-carbolin-9-yl)acetic acids as selective inhibitors for AKR1B1.
Minehira D; Takeda D; Urata H; Kato A; Adachi I; Wang X; Matsuya Y; Sugimoto K; Takemura M; Endo S; Matsunaga T; Hara A; Koseki J; Narukawa K; Hirono S; Toyooka N
Bioorg Med Chem; 2012 Jan; 20(1):356-67. PubMed ID: 22104435
[TBL] [Abstract][Full Text] [Related]
4. Design and synthesis of potent and selective aldose reductase inhibitors based on pyridylthiadiazine scaffold.
Chen X; Yang Y; Ma B; Zhang S; He M; Gui D; Hussain S; Jing C; Zhu C; Yu Q; Liu Y
Eur J Med Chem; 2011 May; 46(5):1536-44. PubMed ID: 21367494
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological evaluation of steroidal derivatives as selective inhibitors of AKR1B10.
Zhang W; Wang L; Zhang L; Chen W; Chen X; Xie M; Yan G; Hu X; Xu J; Zhang J
Steroids; 2014 Aug; 86():39-44. PubMed ID: 24793566
[TBL] [Abstract][Full Text] [Related]
6. Structural Determinants of the Selectivity of 3-Benzyluracil-1-acetic Acids toward Human Enzymes Aldose Reductase and AKR1B10.
Ruiz FX; Cousido-Siah A; Porté S; Domínguez M; Crespo I; Rechlin C; Mitschler A; de Lera ÁR; Martín MJ; de la Fuente JÁ; Klebe G; Parés X; Farrés J; Podjarny A
ChemMedChem; 2015 Dec; 10(12):1989-2003. PubMed ID: 26549844
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, in vitro and in silico investigation of aldose reductase inhibitory effects of new thiazole-based compounds.
Sever B; Altıntop MD; Demir Y; Akalın Çiftçi G; Beydemir Ş; Özdemir A
Bioorg Chem; 2020 Sep; 102():104110. PubMed ID: 32739480
[TBL] [Abstract][Full Text] [Related]
8. Novel 2-phenoxypyrido[3,2-
Hao X; Qi G; Ma H; Zhu C; Han Z
J Enzyme Inhib Med Chem; 2019 Dec; 34(1):1368-1372. PubMed ID: 31347930
[TBL] [Abstract][Full Text] [Related]
9. Novel 3,4-dihydroquinolin-2(1H)-one derivatives as dual inhibitor targeting AKR1B1/ROS for treatment of diabetic complications: Design, synthesis and biological evaluation.
Han Z; Qi G; Zhu J; Zhang Y; Xu Y; Yan K; Zhu C; Hao X
Bioorg Chem; 2020 Dec; 105():104428. PubMed ID: 33161249
[TBL] [Abstract][Full Text] [Related]
10. X-ray structure of the V301L aldo-keto reductase 1B10 complexed with NADP(+) and the potent aldose reductase inhibitor fidarestat: implications for inhibitor binding and selectivity.
Ruiz FX; Cousido-Siah A; Mitschler A; Farrés J; Parés X; Podjarny A
Chem Biol Interact; 2013 Feb; 202(1-3):178-85. PubMed ID: 23295227
[TBL] [Abstract][Full Text] [Related]
11. Design and synthesis of potent and multifunctional aldose reductase inhibitors based on quinoxalinones.
Qin X; Hao X; Han H; Zhu S; Yang Y; Wu B; Hussain S; Parveen S; Jing C; Ma B; Zhu C
J Med Chem; 2015 Feb; 58(3):1254-67. PubMed ID: 25602762
[TBL] [Abstract][Full Text] [Related]
12. Coumarin-thiazole and -oxadiazole derivatives: Synthesis, bioactivity and docking studies for aldose/aldehyde reductase inhibitors.
Ibrar A; Tehseen Y; Khan I; Hameed A; Saeed A; Furtmann N; Bajorath J; Iqbal J
Bioorg Chem; 2016 Oct; 68():177-86. PubMed ID: 27544072
[TBL] [Abstract][Full Text] [Related]
13. Inhibitor selectivity between aldo-keto reductase superfamily members AKR1B10 and AKR1B1: role of Trp112 (Trp111).
Zhang L; Zhang H; Zhao Y; Li Z; Chen S; Zhai J; Chen Y; Xie W; Wang Z; Li Q; Zheng X; Hu X
FEBS Lett; 2013 Nov; 587(22):3681-6. PubMed ID: 24100137
[TBL] [Abstract][Full Text] [Related]
14. Discovery of new inhibitors of aldose reductase from molecular docking and database screening.
Rastelli G; Ferrari AM; Costantino L; Gamberini MC
Bioorg Med Chem; 2002 May; 10(5):1437-50. PubMed ID: 11886806
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis and evaluation of caffeic acid phenethyl ester-based inhibitors targeting a selectivity pocket in the active site of human aldo-keto reductase 1B10.
Soda M; Hu D; Endo S; Takemura M; Li J; Wada R; Ifuku S; Zhao HT; El-Kabbani O; Ohta S; Yamamura K; Toyooka N; Hara A; Matsunaga T
Eur J Med Chem; 2012 Feb; 48():321-9. PubMed ID: 22236472
[TBL] [Abstract][Full Text] [Related]
16. Novel quinazolinone-based 2,4-thiazolidinedione-3-acetic acid derivatives as potent aldose reductase inhibitors.
Metwally K; Pratsinis H; Kletsas D; Quattrini L; Coviello V; Motta C; El-Rashedy AA; Soliman ME
Future Med Chem; 2017 Dec; 9(18):2147-2166. PubMed ID: 29098865
[TBL] [Abstract][Full Text] [Related]
17. Design and synthesis of novel quinazolin-4(1H)-one derivatives as potent and selective inhibitors targeting AKR1B1.
Han Z; Li J; Xu Z; Su Y; Wang Y; Zhuo L; Du J; Zhu C; Hao X
Arch Pharm (Weinheim); 2023 Apr; 356(4):e2200577. PubMed ID: 36707406
[TBL] [Abstract][Full Text] [Related]
18. Highly selective aldose reductase inhibitors. 3. Structural diversity of 3-(arylmethyl)-2,4,5-trioxoimidazolidine-1-acetic acids.
Kotani T; Nagaki Y; Ishii A; Konishi Y; Yago H; Suehiro S; Okukado N; Okamoto K
J Med Chem; 1997 Feb; 40(5):684-94. PubMed ID: 9057855
[TBL] [Abstract][Full Text] [Related]
19. 1,2-Benzothiazine 1,1-dioxide carboxylate derivatives as novel potent inhibitors of aldose reductase.
Chen X; Zhang S; Yang Y; Hussain S; He M; Gui D; Ma B; Jing C; Qiao Z; Zhu C; Yu Q
Bioorg Med Chem; 2011 Dec; 19(23):7262-9. PubMed ID: 22036211
[TBL] [Abstract][Full Text] [Related]
20. Identification of a novel polyfluorinated compound as a lead to inhibit the human enzymes aldose reductase and AKR1B10: structure determination of both ternary complexes and implications for drug design.
Cousido-Siah A; Ruiz FX; Mitschler A; Porté S; de Lera ÁR; Martín MJ; Manzanaro S; de la Fuente JA; Terwesten F; Betz M; Klebe G; Farrés J; Parés X; Podjarny A
Acta Crystallogr D Biol Crystallogr; 2014 Mar; 70(Pt 3):889-903. PubMed ID: 24598757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
